Show/Hide Menu
Hide/Show Apps
anonymousUser
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Videos
Videos
Thesis submission
Thesis submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Contact us
Contact us
Quinoides and VEGFR2 TKIs influence the fate of hepatocellular carcinoma and its cancer stem cells.
Date
2016-10-07
Author
Kahraman, Deniz Cansen
Hanquet, Gilles
Jeanmart, Loic
Lanners, Steve
Sramel, Peter
Bohac, Andrej
Atalay, Rengül
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
7
views
0
downloads
Cite This
Bioactivities of quinoides 1-5 and VEGFR2 TKIs 6-10 in hepatocellular cancer (HCC) and cancer stem cells (HCSCs) were studied. The compounds exhibited IC50 values in mu M concentrations in HCC cells. Quinoide 3 was able to eradicate cancer stem cells, similar to the action of the stem cell inhibitor DAPT. However, the more cytotoxic VEFGR TKIs (IC50: 0.4-3.0 mu M) including sorafenib, which is the only FDA approved drug for the treatment of HCC, enriched the hepatocellular cancer stem cell population by 2-3 fold after treatment. An aggressiveness factor (AF) was proposed to quantify the characteristics of drug candidates for their ability to eradicate the CSC subpopulation. Considering the tumour heterogeneity and marker positive cancer stem cell like subpopulation enrichment upon treatments in patients, this study emphasises the importance of the chemotherapeutic agent choice acting differentially on all the subpopulations including marker-positive CSCs.
Subject Keywords
Diels-alder reactions
,
Liver-cancer
,
Chemistry
,
Toxicity
URI
https://hdl.handle.net/11511/32282
Journal
MedChemComm
DOI
https://doi.org/10.1039/c6md00392c
Collections
Graduate School of Informatics, Article
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
D. C. Kahraman et al., “Quinoides and VEGFR2 TKIs influence the fate of hepatocellular carcinoma and its cancer stem cells.,”
MedChemComm
, vol. 8, no. 1, pp. 81–87, 2016, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/32282.